For Vertex Pharmaceuticals, the first quarter of 2025 brought good news and bad news. | Despite positive early signs for its ...

CEO Reshma Kewalramani highlighted the company’s strong performance in Q1 2025, with $2.77 billion in revenue, representing a 3% year-over-year increase. Growth was driven by expanding patient reach ...

Full abstracts will be released by ASCO on Thursday, May 22, 2025, at 5:00 PM ET. Details from the presentations will be available following the event on the Candel website at Candel Media. * Dr ...

With a market cap of $122.6 billion, Vertex Pharmaceuticals Incorporated (VRTX) operates as a global biotechnology company that develops and commercializes therapies for treating cystic fibrosis (CF).

UBS invites you to the presentation of its first quarter 2025 results on Wednesday, 30 April 2025. They will be presented by Sergio P. Ermotti, Group Chief Executive Officer, Todd Tuckner, Group Chief ...

Regulatory submissions are expected in 2026, and if approved, would be the second cell therapy for type 1 diabetes. Vertex Pharmaceuticals is conducting the pivotal phase 3 portion of a phase 1/2/3 ...

She reiterated her buy recommendation on Vertex stock, and kept her $583-per-share price target intact. According to reports, Merle's update was based on surveys with medical professionals ...

The Elder Scrolls IV: Oblivion Remastered is here! Experience the beloved classic with a modern look and refined suite of features and updates. Bethesda Game Studios’ foundational open world ...

Go from text prompts to slide decks in minutes with CNET's guide on creating a PowerPoint presentation using artificial intelligence tools. Amanda Smith is a freelance journalist and writer.

Everyone has been there – that moment when you’re watching someone who clearly knows their stuff deliver a presentation that just falls apart. I still cringe thinking about the time I ...